Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678909 · ClinicalTrials.gov registry record
Cardiac Biomarkers in Patients With Single Ventricle Physiology
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 19
- Enrollment target
NCT03678909 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 19 participants.
The verdict
NCT03678909 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
All neonates with congenital heart disease undergoing stage one palliation (Norwood procedure, Damus-Kaye-Stansel procedure) at Texas Children's Hospital will be regularly monitored for B-type natriuretic peptide (BNP) and Troponin level before the surgical procedure, on arrival to the cardiac intensive care unit after their surgical procedure, every 6 hours during the first 24 hours of the post-operative period, followed by daily levels for the first week, and then weekly during patient's regular laboratory work up schedule. These cardiac biomarkers are linked to demographic, hemodynamic, respiratory, pharmacological data available via Sickbay.
Interventions
- PROCEDURE Norwood Palliation / DKS / Damus-Kaye-Stansel procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2020-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03678909
The ClinicalTrials.gov registry entry for NCT03678909 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Norwood Palliation / DKS / Damus-Kaye-Stansel procedure is the first listed.
NCT03678909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03678909 about?
NCT03678909 is a clinical study titled "Cardiac Biomarkers in Patients With Single Ventricle Physiology". All neonates with congenital heart disease undergoing stage one palliation (Norwood procedure, Damus-Kaye-Stansel procedure) at Texas Children's Hospital will be regularly monitored for B-type natriuretic peptide (BNP) and Troponin level before the surgical procedure, on arrival to the cardiac inten...
What is the current status of trial NCT03678909?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2018-03-01. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT03678909?
The interventions under investigation include: Norwood Palliation / DKS / Damus-Kaye-Stansel procedure (PROCEDURE).
Who is sponsoring clinical trial NCT03678909?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.